Overview

Gina Ogilvie, MD MSc FCFP DrPH is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at the University of British Columbia in the School of Population and Public Health. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre.

Dr. Ogilvie is currently principal investigator on over $13-million in research grants and she has received funding from PHAC, CIHR, Michael Smith Foundation for Health Research, Canadian Foundation for Innovation and private foundations including BC Women’s Hospital Foundation among others.

Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally.

She has published over 100 peer reviewed manuscripts and has provided advice and consultation to national and global institutions, including the Canadian Partnership Against Cancer, Public Health Agency of Canada, the World Health Organization and Ministries of Health globally on STI, HIV and HPV vaccine policy and programming.

She speaks widely at international and national research and education conferences, and has supervised medical students, residents, and graduate students throughout her career.

Publications

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
Tota JE and Bentley J and Blake J and Coutlée F and Duggan MA and Ferenczy A and Franco EL and Fung-Kee-Fung M and Gotlieb W and Mayrand MH and McLachlin M and Murphy J and Ogilvie G and Ratnam S
DOI: 10.1016/j.ypmed.2016.11.029
PubMed: 28279264
05/2017

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
Tota JE and Bentley J and Blake J and Coutlée F and Duggan MA and Ferenczy A and Franco EL and Fung-Kee-Fung M and Gotlieb W and Mayrand MH and McLachlin M and Murphy J and Ogilvie G and Ratnam S
DOI: 10.1016/j.ypmed.2016.11.030
PubMed: 28279257
05/2017

Improving linkage to HIV care at low-threshold STI/HIV testing sites: An evaluation of the Immediate Staging Pilot Project in Vancouver, British Columbia.
Brownrigg B and Taylor D and Phan F and Sandstra I and Stimpson R and Barrios R and Lester R and Ogilvie G
DOI: 10.17269/cjph.108.5753
PubMed: 28425903
04/2017

Awareness and understanding of HIV non-disclosure case law among people living with HIV who use illicit drugs in a Canadian setting.
Patterson S and Kaida A and Ogilvie G and Hogg R and Nicholson V and Dobrer S and Kerr T and Shoveller J and Montaner J and Milloy MJ
DOI: 10.1016/j.drugpo.2017.02.003
PubMed: 28363120
03/2017

Use of GetCheckedOnline, a Comprehensive Web-based Testing Service for Sexually Transmitted and Blood-Borne Infections.
Gilbert M and Salway T and Haag D and Fairley CK and Wong J and Grennan T and Uddin Z and Buchner CS and Wong T and Krajden M and Tyndall M and Shoveller J and Ogilvie G
DOI: 10.2196/jmir.7097
PubMed: 28320690
03/2017

Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Mezei AK and Armstrong HL and Pedersen HN and Campos NG and Mitchell SM and Sekikubo M and Byamugisha JK and Kim JJ and Bryan S and Ogilvie GS
DOI: 10.1002/ijc.30695
PubMed: 28297074
03/2017

On the duration of the period between exposure to HIV and detectable infection.
Konrad BP and Taylor D and Conway JM and Ogilvie GS and Coombs D
DOI: 10.1016/j.epidem.2017.03.002
PubMed: 28365331
03/2017

Evidence that supports policies to delay cervical screening until after age 25 years.
Dickinson JA and Ogilvie G and Van Niekerk D and Popadiuk C
DOI: 10.1503/cmaj.160636
PubMed: 28385818
03/2017

Sustained Reduction in Sexual Behavior that May Pose a Risk of HIV Transmission Following Diagnosis During Early HIV Infection Among Gay Men in Vancouver, British Columbia.
Gilbert M and Taylor D and Michelow W and Grace D and Balshaw R and Kwag M and Lim E and Fischer B and Patrick D and Ogilvie G and Coombs D and Steinberg M and Rekart M
DOI: 10.1007/s10461-017-1702-0
PubMed: 28168375
02/2017

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
Cook DA and Smith LW and Law J and Mei W and van Niekerk DJ and Ceballos K and Gondara L and Franco EL and Coldman AJ and Ogilvie GS and Jang D and Chernesky M and Krajden M
DOI: 10.1016/j.jcv.2016.12.004
PubMed: 27988420
02/2017

Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM and Pedersen HN and Eng Stime E and Sekikubo M and Moses E and Mwesigwa D and Biryabarema C and Christilaw J and Byamugisha JK and Money DM and Ogilvie GS
DOI: 10.1186/s12905-016-0360-0
PubMed: 28086933
01/2017

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS and Krajden M and van Niekerk D and Smith LW and Cook D and Ceballos K and Lee M and Gentile L and Gondara L and Elwood-Martin R and Peacock S and Stuart G and Franco EL and Coldman AJ
DOI: 10.1002/ijc.30454
PubMed: 27685757
01/2017

Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study.
Perez S and Tatar O and Shapiro GK and Dubé E and Ogilvie G and Guichon J and Gilca V and Rosberger Z
DOI: 10.1186/s12889-016-3828-9
PubMed: 27919239
12/2016

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.
Coldman AJ and Gondara L and Smith LW and van Niekerk D and Ceballos K and Krajden M and Cook D and Quinlan DJ and Lee M and Stuart GC and Peacock S and Martin RE and Gentile L and Franco EL and Ogilvie GS
DOI: 10.1038/bjc.2016.368
PubMed: 27855441
12/2016

Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A and van Niekerk D and Smith L and Ogilvie G
PubMed: 27810984
11/2016

Get Checked… Where? The Development of a Comprehensive, Integrated Internet-Based Testing Program for Sexually Transmitted and Blood-Borne Infections in British Columbia, Canada.
Gilbert M and Haag D and Hottes TS and Bondyra M and Elliot E and Chabot C and Farrell J and Bonnell A and Kopp S and Andruschak J and Shoveller J and Ogilvie G
DOI: 10.2196/resprot.6293
PubMed: 27649716
09/2016

HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
Money DM and Moses E and Blitz S and Vandriel SM and Lipsky N and Walmsley SL and Loutfy M and Trottier S and Smaill F and Yudin MH and Klein M and Harris M and Cohen J and Wobeser W and Bitnun A and Lapointe N and Samson L and Brophy J and Karatzios C and Ogilvie G
DOI: 10.1016/j.vaccine.2016.08.016
PubMed: 27544584
09/2016

Biomedical technologies for the prevention of sexually transmitted infections and HIV for adolescent girls and young women.
Narasimhan M and Vermund SH and Ogilvie G
PubMed: 27794092
09/2016

Trends in Syphilis Partner Notification Among Gay, Bisexual, and Other Men who Have Sex With Men in British Columbia, 2010 to 2013.
Deonarine A and Ogilvie G and Montgomery C and Makaroff S and Holgerson N and Grennan T and Gilbert M and Wong J
DOI: 10.1097/olq.0000000000000494
PubMed: 27414679
08/2016

Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial.
Smith L and van Niekerk D and Coldman A and Krajden M and Franco EL and Ogilvie G
DOI: 10.1016/j.jogc.2016.04.009
PubMed: 27638983
08/2016

Factors Associated with Productive Recruiting in a Respondent-Driven Sample of Men who Have Sex with Men in Vancouver, Canada.
Forrest JI and Lachowsky NJ and Lal A and Cui Z and Sereda P and Raymond HF and Ogilvie G and Roth EA and Moore D and Hogg RS
DOI: 10.1007/s11524-016-0032-2
PubMed: 26960428
04/2016

Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Ogilvie GS and Smith LW and van Niekerk D and Khurshed F and Pedersen HN and Taylor D and Thomson K and Greene SB and Babich SM and Franco EL and Coldman AJ
DOI: 10.1186/s12889-016-2865-8
PubMed: 26935960
03/2016

Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
Salters KA and Cescon A and Zhang W and Ogilvie G and Murray MC and Coldman A and Hamm J and Chiu CG and Montaner JS and Wiseman SM and Money D and Pick N and Hogg RS
DOI: 10.1111/hiv.12290
PubMed: 26268461
03/2016

Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
Jayasinghe Y and Rangiah C and Gorelik A and Ogilvie G and Wark JD and Hartley S and Garland SM
DOI: 10.1016/j.jcv.2015.10.026
PubMed: 26589584
03/2016

Clinicians' attitude towards changes in Australian National Cervical Screening Program.
Yap D and Liang X and Garland SM and Hartley S and Gorelik A and Ogilvie G and Tan J and Wrede CD and Jayasinghe Y
DOI: 10.1016/j.jcv.2015.11.018
PubMed: 26651602
03/2016

Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.
Cromwell I and Ferreira Z and Smith L and van der Hoek K and Ogilvie G and Coldman A and Peacock SJ
DOI: 10.3747/co.23.2914
PubMed: 26985142
02/2016

Barriers to Cervical Screening Among Sex Workers in Vancouver.
Duff P and Ogilvie G and Shoveller J and Amram O and Chettiar J and Nguyen P and Dobrer S and Montaner J and Shannon K
DOI: 10.2105/ajph.2015.302863
PubMed: 26562102
02/2016

Establishing the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study.
Loutfy M and Greene S and Kennedy VL and Lewis J and Thomas-Pavanel J and Conway T and de Pokomandy A and O'Brien N and Carter A and Tharao W and Nicholson V and Beaver K and Dubuc D and Gahagan J and Proulx-Boucher K and Hogg RS and Kaida A and CHIWOS Research Team
DOI: 10.1186/s12874-016-0190-7
PubMed: 27543135
2016

Strategies for Increasing Cervical Cancer Screening Amongst First Nations Communities in Northwest Ontario, Canada.
Maar M and Wakewich P and Wood B and Severini A and Little J and Burchell AN and Ogilvie G and Zehbe I
DOI: 10.1080/07399332.2014.959168
PubMed: 25375661
2016

Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.
Patterson S and Kaida A and Nguyen P and Dobrer S and Ogilvie G and Hogg R and Kerr T and Montaner J and Wood E and Milloy MJ
DOI: 10.9778/cmajo.20150106
PubMed: 27398360
2016

Strategies for Community Education Prior to Clinical Trial Recruitment for a Cervical Cancer Screening Intervention in Uganda.
Mitchell SM and Pedersen HN and Sekikubo M and Biryabarema C and Byamugisha JJ and Mwesigwa D and Steinberg M and Money DM and Ogilvie GS
DOI: 10.3389/fonc.2016.00090
PubMed: 27148482
2016

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
Cook DA and Mei W and Smith LW and van Niekerk DJ and Ceballos K and Franco EL and Coldman AJ and Ogilvie GS and Krajden M
DOI: 10.1186/s12885-015-1959-5
PubMed: 26674353
12/2015

Health care providers' perspectives on a weekly text-messaging intervention to engage HIV-positive persons in care (WelTel BC1).
Murray MC and O'Shaughnessy S and Smillie K and Van Borek N and Graham R and Maan EJ and van der Kop ML and Friesen K and Albert A and Levine S and Pick N and Ogilvie G and Money D and Lester R and WelTel BC1 Study Team
DOI: 10.1007/s10461-015-1151-6
PubMed: 26297567
10/2015

Predictors identifying those at increased risk for STDs: a theory-guided review of empirical literature and clinical guidelines.
Falasinnu T and Gilbert M and Hottes TS and Gustafson P and Ogilvie G and Shoveller J
DOI: 10.1177/0956462414555930
PubMed: 25324350
10/2015

Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E and Pedersen HN and Mitchell SM and Sekikubo M and Mwesigwa D and Singer J and Biryabarema C and Byamugisha JK and Money DM and Ogilvie GS
DOI: 10.1111/tmi.12549
PubMed: 26031572
10/2015

Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.
Ogilvie GS and Naus M and Money DM and Dobson SR and Miller D and Krajden M and van Niekerk DJ and Coldman AJ
DOI: 10.1002/ijc.29508
PubMed: 25754686
10/2015

Current status of human papillomavirus vaccination.
Brotherton JM and Ogilvie GS
DOI: 10.1097/cco.0000000000000211
PubMed: 26258273
09/2015

'I didn't even know boys could get the vaccine': Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons.
Perez S and Shapiro GK and Brown CA and Dube E and Ogilvie G and Rosberger Z
PubMed: 26152776
07/2015

The relationship between social, policy and physical venue features and social cohesion on condom use for pregnancy prevention among sex workers: a safer indoor work environment scale.
Duff P and Shoveller J and Dobrer S and Ogilvie G and Montaner J and Chettiar J and Shannon K
DOI: 10.1136/jech-2014-204427
PubMed: 25678713
07/2015

Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE and Gratrix J and Martin I and Friedman DS and Hoang L and Lester R and Metz G and Ogilvie G and Read R and Wong T
DOI: 10.1097/olq.0000000000000280
PubMed: 25970311
06/2015

Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program.
Coldman AJ and Phillips N and van Niekerk D and Smith L and Krajden M and Cook D and Quinlan DJ and Ehlen T and Miller D and Stuart GC and Peacock S and Martin RE and Franco EL and Ogilvie G
DOI: 10.1016/s1701-2163(15)30255-3
PubMed: 26168101
05/2015

Pregnancy intentions among female sex workers: recognising their rights and wants as mothers.
Duff P and Shoveller J and Feng C and Ogilvie G and Montaner J and Shannon K
DOI: 10.1136/jfprhc-2012-100532
PubMed: 25056256
04/2015

Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada.
Ling DI and Janjua NZ and Wong S and Krajden M and Hoang L and Morshed M and Achen M and Murti M and Lester RT and Wong J and Ogilvie G and Gilbert M
DOI: 10.1097/olq.0000000000000250
PubMed: 25668648
03/2015

Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling.
Taylor D and Durigon M and Davis H and Archibald C and Konrad B and Coombs D and Gilbert M and Cook D and Krajden M and Wong T and Ogilvie G
DOI: 10.1177/0956462414542987
PubMed: 25033879
03/2015

The impact of criminalization of HIV non-disclosure on the healthcare engagement of women living with HIV in Canada: a comprehensive review of the evidence.
Patterson SE and Milloy MJ and Ogilvie G and Greene S and Nicholson V and Vonn M and Hogg R and Kaida A
DOI: 10.7448/ias.18.1.20572
PubMed: 26701080
2015

Sexual inactivity and sexual satisfaction among women living with HIV in Canada in the context of growing social, legal and public health surveillance.
Kaida A and Carter A and de Pokomandy A and Patterson S and Proulx-Boucher K and Nohpal A and Sereda P and Colley G and O'Brien N and Thomas-Pavanel J and Beaver K and Nicholson VJ and Tharao W and Fernet M and Otis J and Hogg RS and Loutfy M and CHIWOS Research Team
DOI: 10.7448/ias.18.6.20284
PubMed: 26643457
2015

Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis.
Lunny C and Taylor D and Hoang L and Wong T and Gilbert M and Lester R and Krajden M and Ogilvie G
DOI: 10.1371/journal.pone.0132776
PubMed: 26168051
2015

Test uptake and case detection of syphilis, HIV, and hepatitis C among women undergoing prenatal screening in British Columbia, 2007 to 2011.
Kuo M and Money DM and Alvarez M and Buxton JA and Krajden M and Lester RT and Ogilvie G and Gilbert M
DOI: 10.1016/s1701-2163(15)30561-2
PubMed: 24927185
06/2014

A critical appraisal of risk models for predicting sexually transmitted infections.
Falasinnu T and Gustafson P and Hottes TS and Gilbert M and Ogilvie G and Shoveller J
DOI: 10.1097/olq.0000000000000120
PubMed: 24722388
05/2014

Short message service (SMS) interventions for the prevention and treatment of sexually transmitted infections: a systematic review protocol.
Lunny C and Taylor D and Memetovic J and Wärje O and Lester R and Wong T and Ho K and Gilbert M and Ogilvie G
DOI: 10.1186/2046-4053-3-7
PubMed: 24433348
01/2014

Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa.
Mitchell SM and Sekikubo M and Biryabarema C and Byamugisha JJ and Steinberg M and Jeronimo J and Money DM and Christilaw J and Ogilvie GS
DOI: 10.1016/j.ajog.2013.08.038
PubMed: 23999419
01/2014

Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.
Krajden M and Cook D and Yu A and Chow R and Su Q and Mei W and McNeil S and Money D and Dionne M and Palefsky J and Karunakaran K and Kollmann T and Ogilvie G and Petric M and Dobson S
DOI: 10.1016/j.vaccine.2013.09.007
PubMed: 24055350
01/2014

Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW and Khurshed F and van Niekerk DJ and Krajden M and Greene SB and Hobbs S and Coldman AJ and Franco EL and Ogilvie GS
DOI: 10.1186/1471-2458-14-1060
PubMed: 25303975
2014

Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.
Teng FF and Mitchell SM and Sekikubo M and Biryabarema C and Byamugisha JK and Steinberg M and Money DM and Ogilvie GS
DOI: 10.1136/bmjopen-2014-004783
PubMed: 24727360
2014

Using community engagement to inform and implement a community-randomized controlled trial in the anishinaabek cervical cancer screening study.
Wood B and Burchell AN and Escott N and Little J and Maar M and Ogilvie G and Severini A and Bishop L and Morrisseau K and Zehbe I
DOI: 10.3389/fonc.2014.00027
PubMed: 24600584
2014

Time since last negative HIV test among men who have sex with men and people who use injection drugs in British Columbia, 2006-2011.
Gilbert M and Hottes TS and Lester R and Gustafson R and Krajden M and Ogilvie G
PubMed: 24735699
2014

Factors associated with intention to use internet-based testing for sexually transmitted infections among men who have sex with men.
Gilbert M and Hottes TS and Kerr T and Taylor D and Fairley CK and Lester R and Wong T and Trussler T and Marchand R and Shoveller J and Ogilvie G
DOI: 10.2196/jmir.2888
PubMed: 24240644
11/2013

Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol.
Taylor D and Lunny C and Wong T and Gilbert M and Li N and Lester R and Krajden M and Hoang L and Ogilvie G
DOI: 10.1186/2046-4053-2-93
PubMed: 24112441
10/2013

Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
Brisson M and Laprise JF and Drolet M and Van de Velde N and Franco EL and Kliewer EV and Ogilvie G and Deeks SL and Boily MC
DOI: 10.1016/j.vaccine.2013.06.064
PubMed: 23830974
08/2013

Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda.
Ogilvie GS and Mitchell S and Sekikubo M and Biryabarema C and Byamugisha J and Jeronimo J and Miller D and Steinberg M and Money DM
DOI: 10.1016/j.ijgo.2013.03.019
PubMed: 23731506
08/2013

Exploring colposcopists' attitudes towards use of HPV testing as a primary screening tool for cervical cancer in British Columbia.
Regier DA and van der Hoek K and Ogilvie G and Smith L and Henwood E and Miller DM and McTaggart-Cowan H and Peacock SJ
PubMed: 23876645
07/2013

Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis.
Rossi G and Bertani C and Mari S and Marini C and Renzoni G and Ogilvie G and Magi GE
DOI: 10.1007/s11259-013-9550-5
PubMed: 23315207
06/2013

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
Dobson SR and McNeil S and Dionne M and Dawar M and Ogilvie G and Krajden M and Sauvageau C and Scheifele DW and Kollmann TR and Halperin SA and Langley JM and Bettinger JA and Singer J and Money D and Miller D and Naus M and Marra F and Young E
DOI: 10.1001/jama.2013.1625
PubMed: 23632723
05/2013

High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
Snijders PJ and Verhoef VM and Arbyn M and Ogilvie G and Minozzi S and Banzi R and van Kemenade FJ and Heideman DA and Meijer CJ
DOI: 10.1002/ijc.27790
PubMed: 22907569
05/2013

Community-based HIV and STI prevention in women working in indoor sex markets.
Bungay V and Kolar K and Thindal S and Remple VP and Johnston CL and Ogilvie G
DOI: 10.1177/1524839912447189
PubMed: 22885289
03/2013

Gonorrhea as a moving target: how do we sharpen our aim and strengthen our arrows?
Yudin MH and Salway Hottes T and Ogilvie GS
DOI: 10.1016/s1701-2163(15)31024-0
PubMed: 23470069
02/2013

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS and Cook DA and Taylor DL and Rank C and Kan L and Yu A and Mei W and van Niekerk DJ and Coldman AJ and Krajden M
DOI: 10.1016/j.vaccine.2012.09.085
PubMed: 23273510
02/2013

Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS and Lester RT and Hoang LM and McKay R and Imperial M and Gilbert M and Patrick D and Wong T and Martin I and Ogilvie G
DOI: 10.1097/olq.0b013e31827bd64c
PubMed: 23250301
01/2013

A qualitative study of provider perspectives of structural barriers to cervical cancer screening among first nations women.
Maar M and Burchell A and Little J and Ogilvie G and Severini A and Yang JM and Zehbe I
DOI: 10.1016/j.whi.2013.06.005
PubMed: 23993479
2013

Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.
Gentschev I and Patil SS and Adelfinger M and Weibel S and Geissinger U and Frentzen A and Chen NG and Yu YA and Zhang Q and Ogilvie G and Szalay AA
DOI: 10.4161/bioe.22462
PubMed: 23093804
2013

A brief tool to assess capacity to consent for medical care among homeless individuals with problematic substance use: study protocol.
Taylor D and Masse L and Ho A and Rekart ML and Tyndall M and Henry B and Clifton J and Peters L and Ogilvie G and Buxton J
DOI: 10.1186/0778-7367-71-11
PubMed: 23651056
2013

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS and Krajden M and van Niekerk DJ and Martin RE and Ehlen TG and Ceballos K and Smith LW and Kan L and Cook DA and Peacock S and Stuart GC and Franco EL and Coldman AJ
DOI: 10.1038/bjc.2012.489
PubMed: 23169286
12/2012

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M and Ronco G and Anttila A and Meijer CJ and Poljak M and Ogilvie G and Koliopoulos G and Naucler P and Sankaranarayanan R and Peto J
DOI: 10.1016/j.vaccine.2012.06.095
PubMed: 23199969
11/2012

Masculinities, 'guy talk' and 'manning up': a discourse analysis of how young men talk about sexual health.
Knight R and Shoveller JA and Oliffe JL and Gilbert M and Frank B and Ogilvie G
DOI: 10.1111/j.1467-9566.2012.01471.x
PubMed: 22471843
11/2012

Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
Steben M and Jeronimo J and Wittet S and Lamontagne DS and Ogilvie G and Jensen C and Smith J and Franceschi S
DOI: 10.1016/j.vaccine.2012.06.031
PubMed: 23199962
11/2012

Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs.
Rank C and Gilbert M and Ogilvie G and Jayaraman GC and Marchand R and Trussler T and Hogg RS and Gustafson R and Wong T and ManCount Study Team
DOI: 10.1016/j.vaccine.2012.07.001
PubMed: 22796376
08/2012

Management of group B streptococcal bacteriuria in pregnancy.
Allen VM and Yudin MH and Bouchard C and Boucher M and Caddy S and Castillo E and Money DM and Murphy KE and Ogilvie G and Paquet C and van Schalkwyk J and Senikas V and Infectious Diseases Committee and Society of Obstetricians and Gynaecologists of Canada
PubMed: 22555143
05/2012

Rethinking cervical cancer screening.
Van Niekerk D and Ogilvie G and Miller D
PubMed: 22555131
05/2012

Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination.
Smolen KK and Gelinas L and Franzen L and Dobson S and Dawar M and Ogilvie G and Krajden M and Fortuno ES and Kollmann TR
DOI: 10.1016/j.vaccine.2012.03.051
PubMed: 22469863
05/2012

High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study.
Loutfy M and Raboud J and Wong J and Yudin M and Diong C and Blitz S and Margolese S and Hart T and Ogilvie G and Masinde K and Tharao W and Linklater G and Salam K and Ongoiba F and Angel J and Smaill F and Rachlis A and Ralph E and Walmsley S and Ontario HIV Fertility Research Team
DOI: 10.1111/j.1468-1293.2011.00946.x
PubMed: 22103297
02/2012

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.
Patil SS and Gentschev I and Nolte I and Ogilvie G and Szalay AA
DOI: 10.1186/1479-5876-10-3
PubMed: 22216938
01/2012

Online sexual health services: examining youth's perspectives.
Shoveller J and Knight R and Davis W and Gilbert M and Ogilvie G
PubMed: 22338322
2012

Feasibility of incorporating self-collected rectal swabs into a community venue-based survey to measure the prevalence of HPV infection in men who have sex with men.
Gilbert M and Kwag M and Mei W and Rank C and Kropp R and Severini A and van Niekerk D and Zhou C and Press N and Ogilvie G and Wong T and ManCount Study Team
DOI: 10.1097/olq.0b013e318222899d
PubMed: 21934574
10/2011

Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda.
Mitchell S and Ogilvie G and Steinberg M and Sekikubo M and Biryabarema C and Money D
DOI: 10.1016/j.ijgo.2011.01.028
PubMed: 21669428
08/2011

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.
Krajden M and Cook D and Yu A and Chow R and Mei W and McNeil S and Money D and Dionne M and Karunakaran KP and Palefsky JM and Dobson S and Ogilvie G and Petric M
DOI: 10.1128/cvi.00489-10
PubMed: 21248158
03/2011

Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
Oteng B and Marra F and Lynd LD and Ogilvie G and Patrick D and Marra CA
DOI: 10.1136/sti.2009.041392
PubMed: 20956352
02/2011

Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.
Gilbert M and Li X and Petric M and Krajden M and Isaac-Renton JL and Ogilvie G and Rekart ML
PubMed: 21714324
2011

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt.
Ogilvie G and Anderson M and Marra F and McNeil S and Pielak K and Dawar M and McIvor M and Ehlen T and Dobson S and Money D and Patrick DM and Naus M
DOI: 10.1371/journal.pmed.1000270
PubMed: 20454567
05/2010

[Cytomegalovirus infection in pregnancy].
Yinon Y and Farine D and Yudin MH and Gagnon R and Hudon L and Basso M and Bos H and Delisle MF and Menticoglou S and Mundle W and Ouellet A and Pressey T and Roggensack A and Boucher M and Castillo E and Gruslin A and Money DM and Murphy K and Ogilvie G and Paquet C
PubMed: 20500944
04/2010

Cytomegalovirus infection in pregnancy.
Yinon Y and Farine D and Yudin MH and Gagnon R and Hudon L and Basso M and Bos H and Delisle MF and Menticoglou S and Mundle W and Ouellet A and Pressey T and Roggensack A and Boucher M and Castillo E and Gruslin A and Money DM and Murphy K and Ogilvie G and Paquet C
PubMed: 20500943
04/2010

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial).
Ogilvie GS and van Niekerk DJ and Krajden M and Martin RE and Ehlen TG and Ceballos K and Peacock SJ and Smith LW and Kan L and Cook DA and Mei W and Stuart GC and Franco EL and Coldman AJ
DOI: 10.1186/1471-2407-10-111
PubMed: 20334685
03/2010

Primary health care: applying the principles within a community-based participatory health research project that began in a Canadian women's prison.
Martin RE and Murphy K and Chan R and Ramsden VR and Granger-Brown A and Macaulay AC and Kahlon R and Ogilvie G and Hislop TG
DOI: 10.1177/1757975909348114
PubMed: 20028668
12/2009

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia.
Krajden M and Karunakaran K and So S and Palefsky JM and Sharma R and Cook D and Yu A and Chow R and Dobson S and Ogilvie GS and Petric M
DOI: 10.1128/cvi.00238-09
PubMed: 19828766
12/2009

Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.
Moore RA and Ogilvie G and Fornika D and Moravan V and Brisson M and Amirabbasi-Beik M and Kollar A and Burgess T and Hsu R and Towers L and Lo J and Matisic J and Brooks-Wilson A
DOI: 10.1007/s10552-009-9365-4
PubMed: 19475481
10/2009

Antibiotic therapy in preterm premature rupture of the membranes.
Yudin MH and van Schalkwyk J and Van Eyk N and Boucher M and Castillo E and Cormier B and Gruslin A and Money DM and Murphy K and Ogilvie G and Paquet C and Steenbeek A and Wong T and Gagnon R and Hudon L and Basso M and Bos H and Delisle MF and Farine D and Grabowska K
PubMed: 19941711
09/2009

A population-based study of infectious syphilis rediagnosis in British Columbia, 1995-2005.
Ogilvie GS and Taylor DL and Moniruzzaman A and Knowles L and Jones H and Kim PH and Rekart ML
DOI: 10.1086/598997
PubMed: 19402790
06/2009

Self-collection of genital human papillomavirus specimens in heterosexual men.
Ogilvie GS and Taylor DL and Achen M and Cook D and Krajden M
DOI: 10.1136/sti.2008.033068
PubMed: 19066196
06/2009

Patients with genital warts have a decreased quality of life.
Marra C and Ogilvie G and Gastonguay L and Colley L and Taylor D and Marra F
DOI: 10.1097/olq.0b013e318191a55e
PubMed: 19265737
04/2009

Epidemiology and costs associated with genital warts in Canada.
Marra F and Ogilvie G and Colley L and Kliewer E and Marra CA
DOI: 10.1136/sti.2008.030999
PubMed: 18981170
04/2009

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review.
Marra F and Cloutier K and Oteng B and Marra C and Ogilvie G
DOI: 10.2165/00019053-200927020-00004
PubMed: 19254046
2009

Immunization in pregnancy.
Gruslin A and Steben M and Halperin S and Money DM and Yudin MH and Boucher M and Cormier B and Ogilvie G and Paquet C and Steenbeek A and Van Eyk N and van Schalkwyk J and Wong T
PubMed: 19175969
12/2008

Intention of parents to have male children vaccinated with the human papillomavirus vaccine.
Ogilvie GS and Remple VP and Marra F and McNeil SA and Naus M and Pielak K and Ehlen T and Dobson S and Patrick DM and Money DM
DOI: 10.1136/sti.2007.029389
PubMed: 18445636
08/2008

Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?
Günther OP and Ogilvie G and Naus M and Young E and Patrick DM and Dobson S and Duval B and Noël PA and Marra F and Miller D and Brunham RC and Pourbohloul B
DOI: 10.1086/588140
PubMed: 18513154
06/2008

Perceptions of sexual partner safety.
Masaro CL and Dahinten VS and Johnson J and Ogilvie G and Patrick DM
DOI: 10.1097/olq.0b013e3181660c43
PubMed: 18354343
06/2008

Trends in sexual health and risk behaviours among adolescent students in British Columbia.
Saewyc EM and Taylor D and Homma Y and Ogilvie G
PubMed: 23115485
01/2008

Seeking sexual partners on the internet: a marker for risky sexual behaviour in men who have sex with men.
Ogilvie GS and Taylor DL and Trussler T and Marchand R and Gilbert M and Moniruzzaman A and Rekart ML
PubMed: 18615938
2008

Parental intention to have daughters receive the human papillomavirus vaccine.
Ogilvie GS and Remple VP and Marra F and McNeil SA and Naus M and Pielak KL and Ehlen TG and Dobson SR and Money DM and Patrick DM
DOI: 10.1503/cmaj.071022
PubMed: 18056599
12/2007

Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women.
Ogilvie G and Krajden M and Maginley J and Isaac-Renton J and Hislop G and Elwood-Martin R and Sherlock C and Taylor D and Rekart M
DOI: 10.1503/cmaj.070013
PubMed: 17724326
08/2007

Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada.
Ogilvie GS and Palepu A and Remple VP and Maan E and Heath K and MacDonald G and Christilaw J and Berkowitz J and Fisher WA and Burdge DR
DOI: 10.1097/01.aids.0000255090.51921.60
PubMed: 17159593
01/2007

Sustained increase in HIV-1 incidence since 2000 among men who have sex with men in British Columbia, Canada.
Lampinen TM and Ogilvie G and Chan K and Miller ML and Cook D and Schechter MT and Hogg RS
DOI: 10.1097/01.qai.0000168182.14523.d4
PubMed: 16186747
10/2005

The impact of syphilis mass treatment one year later: self-reported behaviour change among participants.
Rekart ML and Wong T and Wong E and Hutchinson K and Ogilvie G
DOI: 10.1258/0956462054679179
PubMed: 16105193
08/2005

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis.
Ogilvie GS and Patrick DM and Schulzer M and Sellors JW and Petric M and Chambers K and White R and FitzGerald JM
DOI: 10.1136/sti.2004.011858
PubMed: 15923286
06/2005

Incorporating a social networking approach to enhance contact tracing in a heterosexual outbreak of syphilis.
Ogilvie G and Knowles L and Wong E and Taylor D and Tigchelaar J and Brunt C and James L and Maginley J and Jones H and Rekart ML
DOI: 10.1136/sti.2003.009019
PubMed: 15800088
04/2005

Report of the 2003 pan-Canadian forum on cervical cancer prevention and control.
Stuart G and Taylor G and Bancej CM and Beaulac J and Colgan T and Franco EL and Kropp RY and Lotocki R and Mai V and McLachlin CM and Onysko J and Martin RE and Elit L and Guijon F and Mann J and Ogilvie G and Romanowski B and Tromp M and Society of Gynecologic Oncologists of Canada and Cervical Cancer Prevention Network of Canada
PubMed: 15560864
11/2004

Access to colposcopy services for high-risk Canadian women: can we do better?
Ogilvie GS and Shaw EA and Lusk SP and Zazulak J and Kaczorowski JA
PubMed: 15490923
2004

Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Alimenti A and Burdge DR and Ogilvie GS and Money DM and Forbes JC
DOI: 10.1097/01.inf.0000086400.93257.74
PubMed: 14506368
09/2003

Research

Current Projects
Among other research projects, she is principal investigator for the ASPIRE program, a global health initiative conducting research and providing women-centred, innovative solutions for cervical cancer prevention and reproductive health in sub-Saharan Africa. She also leads HPV FOCAL, which is a randomized trial of over 25,000 women comparing primary screening for cervical cancer, and QUEST, a pragmatic randomized trial defining the effectiveness of reduced dosing of the HPV vaccine.

Grants

Michael Smith Foundation for Health Research Quadrivalent vaccine evaluation study (QUEST) 2012-2024

CIHR Foundation Scheme Integrated global control of HPV related disease and cancer 2015-2022

CIHR A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening 2007-2016

Honours & Awards

Recipient, Distinguished Achievement Award, Applied or Clinical Research, Faculty of Medicine, University of British Columbia

Recipient, Researcher of the Year for BC Chapter of Family Physicians, College of Family Physicians of Canada, July 2014

Canada Research Chair, Tier I “Global control of HPV related disease and cancer” April 2015-April 2022

Research Group Members

Jessica Bow, Research Assistant (on leave)
Robine Donken
Sarai Racey
Clara Rubincam